Human Primary Ovarian Tumor Cells

Product Name	Human Primary Ovarian Tumor Cells
Cat.No	RPC-1142
Size	5*10^5 cells/vial
Description	Human Primary Ovarian Tumor Cells are isolated directly from ovarian tumor tissues of patients, offering a biologically relevant model for studying ovarian cancer pathogenesis, drug responses, and personalized therapeutic strategies. Unlike immortalized cell lines, these primary cells retain the genetic, epigenetic, and phenotypic heterogeneity of the original tumor, making them invaluable for translational research.
Tissue	Ovarian cancer tissue
Species	Human
Disease	Ovarian cancer
Biosafety Level	BSL 1. Runtogen determines the biosafety level of a material based on our risk assessment as guided by the current edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL), U.S. Department of Health and Human Services.
Quality Control	Human Primary Ovarian Tumor Cells are negative for mycoplasma, bacteria, yeast, and fungi.
Shipping	Cryopreserved cells are shipped with dry ice
Storage	Upon arrival, Check all containers for leakage or breakage. Remove the frozen cells from the dry ice packaging and immediately place the cells at a temperature below -130°C, preferably in liquid nitrogen vapor, until ready for use.
Warranty	Human Primary Ovarian Tumor Cells are warranted for 30 days from the date of shipment, provided that the customer has stored and handled the product according to the information included on the product datasheet, website, and COA.
Disclaimers	Human Primary Ovarian Tumor Cells are intended for laboratory research use only. It is not intended for any human or animal therapeutic use, any animal or human consumption, or any diagnostic use. Any proposed commercial use is prohibited without a license from Runtogen.

Human Primary Ovarian Tumor Cells

Online Inquiry

Online Inquiry